Zentalis Pharmaceuticals Llc Stock Probability of Future Stock Price Finishing Over 9.28
| ZNTL Stock | USD 3.48 0.02 0.57% |
Zentalis |
Zentalis Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Zentalis Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Zentalis Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Zentalis Pharmaceuticals had very high historical volatility over the last 90 days | |
| Zentalis Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (292.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zentalis Pharmaceuticals Llc currently holds about 455.22 M in cash with (207.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.99, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 98.0% of the company outstanding shares are owned by institutional investors |
Zentalis Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Zentalis Stock often depends not only on the future outlook of the current and potential Zentalis Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zentalis Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 65.4 M | |
| Cash And Short Term Investments | 482.9 M |
Zentalis Pharmaceuticals Technical Analysis
Zentalis Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Zentalis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Zentalis Pharmaceuticals Llc. In general, you should focus on analyzing Zentalis Stock price patterns and their correlations with different microeconomic environments and drivers.
Zentalis Pharmaceuticals Predictive Forecast Models
Zentalis Pharmaceuticals' time-series forecasting models is one of many Zentalis Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Zentalis Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Zentalis Pharmaceuticals
Checking the ongoing alerts about Zentalis Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Zentalis Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Zentalis Pharmaceuticals had very high historical volatility over the last 90 days | |
| Zentalis Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (292.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zentalis Pharmaceuticals Llc currently holds about 455.22 M in cash with (207.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.99, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 98.0% of the company outstanding shares are owned by institutional investors |
Check out Zentalis Pharmaceuticals Backtesting, Zentalis Pharmaceuticals Valuation, Zentalis Pharmaceuticals Correlation, Zentalis Pharmaceuticals Hype Analysis, Zentalis Pharmaceuticals Volatility, Zentalis Pharmaceuticals History as well as Zentalis Pharmaceuticals Performance. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis Pharmaceuticals. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zentalis Pharmaceuticals is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zentalis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zentalis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.